Close Menu

NEW YORK (GenomeWeb) – Investment bank Piper Jaffray today upgraded the stock of Quidel to Overweight after the company said it had amended its previously announced acquisition of Alere's Triage B-type naturietic peptide assay business, an adjustment viewed as favorable to Quidel by several investment analysts.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.